MedRhythms, Inc.
PrivateLast Round
VC Round
Feb 13, 2026
Total Funding Raised
$35.72M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
MedRhythms, Inc. operates in Healthcare & Life Sciences and is based in Portland, Maine. Its latest recorded funding round was a VC Round in February 2026.
MedRhythms, Inc. is a healthcare technology and neurorehabilitation company that develops digital therapeutics and provides neurologic music therapy interventions to improve walking and functional outcomes for patients with neurologic injuries and diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B2C
Customer Profile
Government Contracts, Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MedRhythms, Inc. Comparables
Compare MedRhythms, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Click Therapeutics | 76% | |
| MindMaze | 73% | |
| Neurofenix | 73% |
For institutional investors. Book with your work email.
MedRhythms, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 13, 2026 | ||||
| VC Round | Nov 27, 2023 | ||||
| Series B Extension | Nov 16, 2021 | ||||
| Series B | Jul 28, 2021 | ||||
| Seed | Aug 22, 2019 | ||||
Series A | Jul 2, 2018 |
For institutional investors. Book with your work email.
MedRhythms, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bose Ventures | Series B Extension, Series B |
| Advantage Capital | Series B |
| Global Brain Corporation | Series B |
| Morningside Ventures | Series B |
| Werth Family Investment Associates | Series B, Series A |
| Maine Venture Fund | Series A |
| Maine Technology Institute | Debt, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 13, 2026
Completed a VC Round fundraise.
- Jul 28, 2021
$27M round led by Advantage Capital and Morningside Ventures.
For institutional investors. Book with your work email.
MedRhythms, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MedRhythms, Inc.'s valuation, stock price, and market status.
Is MedRhythms, Inc. a public or private company?
MedRhythms, Inc. is a private company.
What is the current stock price of MedRhythms, Inc.?
MedRhythms, Inc. is a private company, so its shares have no public market price. Caplight tracks MedRhythms, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MedRhythms, Inc. worth (valuation)?
Valuation information for MedRhythms, Inc. is not publicly available.
Can I buy MedRhythms, Inc. stock?
MedRhythms, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MedRhythms, Inc.'s last funding round?
MedRhythms, Inc.'s most recent funding round was VC Round on February 13, 2026.
Who are the main investors in MedRhythms, Inc.?
Key investors in MedRhythms, Inc. include Advantage Capital, Morningside Ventures, Werth Family Investment Associates.
Will MedRhythms, Inc. IPO soon?
No public IPO plans have been announced for MedRhythms, Inc..
How can I track MedRhythms, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in MedRhythms, Inc.'s shares on secondary markets.